Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives

T Lazarević, A Rilak, ŽD Bugarčić - European journal of medicinal chemistry, 2017 - Elsevier
Metallodrugs offer potential for unique mechanism of drug action based on the choice of the
metal, its oxidation state, the types and number of coordinated ligands and the coordination …

New trends in platinum and palladium complexes as antineoplastic agents

M Fanelli, M Formica, V Fusi, L Giorgi… - Coordination Chemistry …, 2016 - Elsevier
The discovery of cisplatin (cis-Pt (NH 3) 2 Cl 2) as an antineoplastic agent has focussed
attention on the rational design of metal complexes that can be potentially used in cancer …

Bioactivity and development of small non-platinum metal-based chemotherapeutics

MG Ferraro, M Piccolo, G Misso, R Santamaria, C Irace - Pharmaceutics, 2022 - mdpi.com
Countless expectations converge in the multidisciplinary endeavour for the search and
development of effective and safe drugs in fighting cancer. Although they still embody a …

Anticancer activity of palladium-based complexes against triple-negative breast cancer

M Vojtek, MPM Marques, IM Ferreira, H Mota-Filipe… - Drug Discovery …, 2019 - Elsevier
Highlights•TNBC is an unmet medical need with poor survival rates and no targeted
therapy.•TNBC resists conventional chemotherapy and surgical strategies.•A review of 121 …

Remarkably flexible 2, 2′: 6′, 2 ″-terpyridines and their group 8–10 transition metal complexes–Chemistry and applications

RR Panicker, A Sivaramakrishna - Coordination Chemistry Reviews, 2022 - Elsevier
The main purpose of this article is to focus on the diversity created by substitution on
pyridine rings of 2, 2′: 6′, 2 ″-terpyridines (tpy) allowing a fine-tuning of the ligand …

Comprehensive review on tumour active palladium compounds and structure–activity relationships

MN Alam, F Huq - Coordination Chemistry Reviews, 2016 - Elsevier
This article provides a comprehensive review of palladium compounds that have been
evaluated for anticancer activity in vivo or in vitro from the era of discovery of cisplatin up to …

Exploring the potential of metallodrugs as chemotherapeutics for triple negative breast cancer

N Nayeem, M Contel - Chemistry–A European Journal, 2021 - Wiley Online Library
This review focuses on studies of coordination and organometallic compounds as potential
chemotherapeutics against triple negative breast cancer (TNBC) which has one of the …

Anticancer activity of 4′-phenyl-2, 2′: 6′, 2 ″-terpyridines–behind the metal complexation

K Malarz, D Zych, M Kuczak, R Musioł… - European Journal of …, 2020 - Elsevier
Terpyridine complexes are known for their broad biological activities, of which their
anticancer potency is the most extensively studied. Strikingly, free ligand activity has rarely …

[HTML][HTML] Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents

C Icsel, VT Yilmaz, OZ Yesilel, WTA Harrison - European Journal of …, 2024 - Elsevier
Based on the chemotherapeutic success of cisplatin, carboplatin and oxaliplatin as
anticancer drugs, and silver sulfadiazine (AgSDZ) as an antibacterial drug, exploration of the …

Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug …

M Zhou, JC Boulos, EA Omer, HA Rudbari… - European Journal of …, 2023 - Elsevier
The use of cisplatin and its derivatives in cancer treatment triggered the interest in metal-
containing complexes as potential novel anticancer agents. Palladium (II)-based complexes …